NCT02134249View on ClinicalTrials.gov

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Infertility
Interventions
DRUG

Diosmin

2 tab / 8 hs Diosmin ( 500mg) will be given at day of HCG injection and for14 days

DRUG

Cabergoline

1 tab/day Cabergoline( 0.5 mg) will be given at day of HCG injection and for 8 days

Trial Locations (2)

13518

Banha Universty, Banhā

Benha univesity hospital, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT02134249 - Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome | Biotech Hunter | Biotech Hunter